APA (7th ed.) Citation

Kuon, J., Hommertgen, A., Krisam, J., Lasitschka, F., Stenzinger, A., Blasi, M., . . . Thomas, M. (2020). Durvalumab in frail and elderly patients with stage four non-small cell lung cancer: Study protocol of the randomized phase II DURATION trial. Trials, 21, . https://doi.org/10.1186/s13063-020-04280-8

Chicago Style (17th ed.) Citation

Kuon, Jonas, et al. "Durvalumab in Frail and Elderly Patients with Stage Four Non-small Cell Lung Cancer: Study Protocol of the Randomized Phase II DURATION Trial." Trials 21 (2020). https://doi.org/10.1186/s13063-020-04280-8.

MLA (9th ed.) Citation

Kuon, Jonas, et al. "Durvalumab in Frail and Elderly Patients with Stage Four Non-small Cell Lung Cancer: Study Protocol of the Randomized Phase II DURATION Trial." Trials, vol. 21, 2020, https://doi.org/10.1186/s13063-020-04280-8.